Home › Bayer Initiates Phase III Trial of an Investigational Recombinant...
 

Keywords :   


Bayer Initiates Phase III Trial of an Investigational Recombinant...

2013-07-09 06:27:42| Chemicals - Topix.net

Bayer HealthCare today announced the company has started to enroll patients in an international Phase II/III trial to evaluate its investigational compound BAY94-9027 for the treatment of hemophilia A in children.

Tags: iii trial phase bayer

Category:Chemicals

Latest from this category

All news
12.11Benjamin Moore Expands Partnership with Roadie to Accelerate Paint Delivery for DIYers and Pros
11.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
11.11Protech Group Acquires Caldwell Chemical Coatings
11.11Asian Paints Reports 2Q 2024-25 Fiscal Results
10.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
09.11Weekly Recap: Nippon Paint, AkzoNobel, PPG Top This Weeks Stories
08.11Statement from the U.S. Green Building Council on the 2024 Election Results
08.11Axalta Celebrates the Opening of its Global Headquarters in the Philadelphia Navy Yard
Chemicals »
16.11Blu-ray OOO BOX
16.1125
16.1117
16.11
16.11 32kg 4kg 2
16.11Fate
16.11125
16.11MEUCCI
More »